New SureSeq CLL + CNV V3 panel improves understanding of CLL OGT has announced the launch of its enhanced SureSeq CLL + CNV ...

A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during ...

Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status ...

Curve Therapeutics has appointed Rab Prinjha as Chief Research and Development (R&D) Officer. Rab is a proven R&D leader with ...

Process efficiencies – QR codes provide a continuous gateway to the latest PI, reducing the time spent to produce and approve ...

PharmaTimes Marketer of the Year Awards and Communications Awards ...

The update, which was published at the beginning of August 2024, revises the framework for additional risk minimisation ...

Our luminaries look across the pharmaverse with conclusions and curiosity ...

How the UK medical cannabis market is tackling supply chain strain ...

Imagine cruising down a highway, with the hum of the engine and road beneath you, travelling towards your destination. On the ...

We are on the cusp of a new era. With net zero hurtling up the agenda, our industry must view decarbonisation as a wider ...